Lian‐Di Liao

2.4k citations

63 papers · 1.5k indexed · h-index 24

Molecular Biology top 10%
Cancer Research top 5%
Oncology
Pulmonary and Respiratory Medicine top 10%
Immunology

Co-authors: Li‐Yan Xu En‐Min Li Xiu‐E Xu Zhi‐Yong Wu Jian‐Yi Wu Bingli Wu Yang‐Min Xie Jian‐Jun Xie
Topics: RNA modifications and cancer (11 papers)Cellular Mechanics and Interactions (10 papers)Cancer-related gene regulation (10 papers)
Cited by: Cancer Research Molecular Biology Immunology and Allergy
Journals: Nucleic Acids Research PLoS ONE Cancer Research
Partner nations: China Israel United Kingdom

In The Last Decade

Lian‐Di Liao

63 papers receiving 1.5k citations

Peers

Countries citing papers authored by Lian‐Di Liao

Since Specialization

Citations

This map shows the geographic impact of Lian‐Di Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lian‐Di Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lian‐Di Liao more than expected).

Fields of papers citing papers by Lian‐Di Liao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lian‐Di Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lian‐Di Liao. The network helps show where Lian‐Di Liao may publish in the future.

Co-authorship network of co-authors of Lian‐Di Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Lian‐Di Liao. A scholar is included among the top collaborators of Lian‐Di Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lian‐Di Liao. Lian‐Di Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CICADA: a circRNA effort toward the ghost proteome 2024 ·Nucleic Acids Research ·(unknown),Xinyuan Zhou,Mian Li,(unknown),Haojie Yu,Hui Tian,Lian‐Di Liao,Li‐Yan Xu,Liang Sun	4
2	Acetyl-CoA Acetyltransferase 2 Confers Radioresistance by Inhibiting Ferroptosis in Esophageal Squamous Cell Carcinoma 2023 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown),(unknown),Luxin Liu,(unknown),(unknown),Xiu‐E Xu,Lian‐Di Liao,(unknown),He-Cheng Huang,En‐Min Li,Li‐Yan Xu	11
3	Blocking STAT3 signaling augments MEK/ERK inhibitor efficacy in esophageal squamous cell carcinoma 2022 ·Cell Death and Disease ·(unknown),(unknown),Wan‐Wan Lin,(unknown),Xiu‐E Xu,Yang Chen,Lian‐Di Liao,Zhiyong Wu,Shaohong Wang,En‐Min Li,Li‐Yan Xu	20
4	Cisplatin-induced pyroptosis is mediated via the CAPN1/CAPN2-BAK/BAX-caspase-9-caspase-3-GSDME axis in esophageal cancer 2022 ·Chemico-Biological Interactions ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Xiu‐E Xu,Lian‐Di Liao,Wan‐Wan Lin,(unknown),He-Cheng Huang,En‐Min Li,Li‐Yan Xu	41
5	P300/CBP‐associated factor (PCAF)‐mediated acetylation of Fascin at lysine 471 inhibits its actin‐bundling activity and tumor metastasis in esophageal cancer 2021 ·Cancer Communications ·Yinwei Cheng,Fa‐Min Zeng,(unknown),Shaohong Wang,Jianzhong He,(unknown),(unknown),Zhi‐Yong Wu,Wenqi Shi,Bing Wen,Xiu‐E Xu,Lian‐Di Liao,(unknown),Jian‐Yi Wu,Jun Zhan,Hongquan Zhang,Zhijie Chang,Kai Zhang,Li‐Yan Xu,En‐Min Li	22
6	LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion 2019 ·Cancer Research ·(unknown),Jiwei Jiao,Haifeng Zhang,Xiu‐E Xu,Jianzhong He,(unknown),Haiying Zou,Zhi‐Yong Wu,Shaohong Wang,Jian‐Yi Wu,Lian‐Di Liao,Sheng Wang,Yinwei Cheng,Kai Zhang,Gera Neufeld,Li‐Yan Xu,En‐Min Li	53
7	LncRNA625 inhibits STAT1-mediated transactivation potential in esophageal cancer cells 2019 ·The International Journal of Biochemistry & Cell Biology ·Guowei Huang,Chunquan Li,Lian‐Di Liao,Jiwei Jiao,Lin Long,(unknown),Jincheng Guo,En‐Min Li,Li‐Yan Xu	9
8	The histone deacetylase inhibitor panobinostat exerts anticancer effects on esophageal squamous cell carcinoma cells by inducing cell cycle arrest 2018 ·Cell Biochemistry and Function ·Yinwei Cheng,Lian‐Di Liao,Qian Yang,Yang Chen,(unknown),Xiaojun Zhang,Jian‐Jun Xie,Baoen Shan,Lianmei Zhao,Li‐Yan Xu,(unknown)	18
9	Riboflavin Depletion Promotes Tumorigenesis in HEK293T and NIH3T3 Cells by Sustaining Cell Proliferation and Regulating Cell Cycle–Related Gene Transcription 2018 ·Journal of Nutrition ·Lin Long,Jianzhong He,Ye Chen,Xiu‐E Xu,Lian‐Di Liao,Yang‐Min Xie,En‐Min Li,Li‐Yan Xu	18
10	Fascin phosphorylation sites combine to regulate esophageal squamous cancer cell behavior 2017 ·Amino Acids ·Fa‐Min Zeng,Xilin Wang,(unknown),Jian‐Jun Xie,Zepeng Du,Lian‐Di Liao,(unknown),Li‐Yan Xu,En‐Min Li	25
11	A truncated splice variant of human lysyl oxidase-like 2 promotes migration and invasion in esophageal squamous cell carcinoma 2016 ·The International Journal of Biochemistry & Cell Biology ·Haiying Zou,Guoqing Lv,Lihua Dai,(unknown),Jiwei Jiao,Lian‐Di Liao,(unknown),Chunquan Li,Bingli Wu,Li‐Yan Xu,En‐Min Li	26
12	Biological characterization of three immortalized esophageal epithelial cell lines 2016 ·Molecular Medicine Reports ·Fa‐Min Zeng,Yang‐Min Xie,Lian‐Di Liao,Liyan Li,Bo Chen,Jian‐Jun Xie,Li‐Yan Xu,En‐Min Li	5
13	Lipocalin 2 promotes the migration and invasion of esophageal squamous cell carcinoma cells through a novel positive feedback loop 2015 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Zepeng Du,Bingli Wu,Yang‐Min Xie,Yingli Zhang,Lian‐Di Liao,Fei Zhou,Jian‐Jun Xie,Fa‐Min Zeng,Xiu‐E Xu,Wang‐Kai Fang,En‐Min Li,Li‐Yan Xu	28
14	12-O-Tetradecanoylphorbol-13-Acetate Induces Up-Regulated Transcription of Variant 1 but Not Variant 2 of VIL2 in Esophageal Squamous Cell Carcinoma Cells via ERK1/2/AP-1/Sp1 Signaling 2015 ·PLoS ONE ·Xiaodan Zhang,Jian‐Jun Xie,Lian‐Di Liao,Lin Long,Yang‐Min Xie,En‐Min Li,Li‐Yan Xu	7
15	Altered expression and localization of desmoglein 3 in esophageal squamous cell carcinoma 2014 ·Acta Histochemica ·Wang‐Kai Fang,Bo Chen,Xiu‐E Xu,Lian‐Di Liao,Zhi‐Yong Wu,Jian‐Yi Wu,Jian Shen,Li‐Yan Xu,En‐Min Li	10
16	DACT2 Is a Candidate Tumor Suppressor and Prognostic Marker in Esophageal Squamous Cell Carcinoma 2013 ·Cancer Prevention Research ·Jian Hou,Lian‐Di Liao,Yang‐Min Xie,Fa‐Min Zeng,Xia Ji,Bo Chen,Liyan Li,Mengxiao Zhu,Cuixia Yang,(unknown),(unknown),Xiu‐E Xu,Jian Shen,Mingzhou Guo,En‐Min Li,Li‐Yan Xu	22
17	Dissection of miRNA-miRNA Interaction in Esophageal Squamous Cell Carcinoma 2013 ·PLoS ONE ·Bingli Wu,Chunquan Li,(unknown),Qianlan Yao,Jian‐Yi Wu,Junwei Han,Lian‐Di Liao,Yanjun Xu,(unknown),(unknown),Li‐Yan Xu,En‐Min Li,Xia Li	25
18	miR-200b suppresses invasiveness and modulates the cytoskeletal and adhesive machinery in esophageal squamous cell carcinoma cells via targeting Kindlin-2 2013 ·Carcinogenesis ·Haifeng Zhang,Kai Zhang,Lian‐Di Liao,Liyan Li,Zepeng Du,Bingli Wu,Jian‐Yi Wu,Xiu‐E Xu,Fa‐Min Zeng,Bo Chen,Huihui Cao,Mengxiao Zhu,Lihua Dai,Lin Long,Zhiyong Wu,Raymond Lai,Li‐Yan Xu,En‐Min Li	47
19	Specificity protein 1 regulates fascin expression in esophageal squamous cell carcinoma as the result of the epidermal growth factor/extracellular signal-regulated kinase signaling pathway activation 2010 ·Cellular and Molecular Life Sciences ·Xiaofeng Lu,En‐Min Li,Zepeng Du,Jian‐Jun Xie,(unknown),Shuying Gao,Lian‐Di Liao,Zhong‐Ying Shen,Dong Xie,Li‐Yan Xu	25
20	Original article: The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features 2010 ·Diseases of the Esophagus ·(unknown),Haijun Zhong,(unknown),Xin Huang,Lian‐Di Liao,(unknown),Xiu‐E Xu,Zhong‐Ying Shen,Li‐Yan Xu,En‐Min Li	64

About Lian‐Di Liao

Lian‐Di Liao is a scholar working on Immunology and Allergy, Cancer Research and Cell Biology, having authored 63 papers that have together received 1.5k indexed citations. Recurring topics across this work include RNA modifications and cancer (11 papers), Cellular Mechanics and Interactions (10 papers) and Cancer-related gene regulation (10 papers). The work is most often cited by research in Cancer Research (505 citations), Molecular Biology (1.1k citations) and Immunology and Allergy (84 citations). Lian‐Di Liao has collaborated with scholars based in China, Israel and United Kingdom. Frequent co-authors include Li‐Yan Xu, En‐Min Li, Xiu‐E Xu, Zhi‐Yong Wu, Jian‐Yi Wu, Bingli Wu, Yang‐Min Xie, Jian‐Jun Xie, Jianzhong He and Zepeng Du. Their work appears in journals such as Nucleic Acids Research, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact